MK-677 · Research brief

How to Mix MK-677 Calculator — Dosing Guide | Real Peptides

Real Peptides Research TeamEditorial

Updated April 10, 20269 min read

54 WORDS

Short answer

Most peptide researchers make their first critical error before they ever touch a syringe. They miscalculate concentration during reconstitution. A 10mg vial reconstituted with 2mL of bacteriostatic water yields 5mg/mL, but researchers frequently assume 10mg/mL and administer double the intended dose without realising it. The difference between precision and guesswork compounds with every administration.

Key takeaways

The mix MK-677 calculator equation is: Final Concentration (mg/mL) = Peptide Mass (mg) ÷ Reconstitution Volume (mL), followed by Injection Volume (mL) = Target Dose (mg) ÷ Concentration (mg/mL).
A 10mg vial reconstituted with 2mL bacteriostatic water yields 5mg/mL, requiring 0.3mL injection volume for a 1.5mg dose.
Vial labels stating 'approximately 10mg' reflect +/- 10% variance due to lyophilisation loss. Calculate using the lower bound (9mg) for multi-week protocols to avoid running short.
Reconstitution with bacteriostatic water (0.9% benzyl alcohol) is mandatory for multi-dose vials stored beyond 24 hours. Sterile water without preservative supports bacterial growth within 48 hours.
Standard 1mL insulin syringes measure volumes between 0.1–1.0mL with acceptable accuracy; doses requiring volumes below 0.1mL need 0.3mL syringes calibrated in 0.005mL increments.
Add 0.5mL to the calculated reconstitution volume for protocols requiring 30+ doses to compensate for residual solution loss during repeated syringe draws.

Our team has walked hundreds of research teams through this exact process. The gap between accurate dosing and dangerous improvisation comes down to understanding three variables most protocols ignore: peptide mass in milligrams, reconstitution volume in millilitres, and target dose per administration.

How do you use a mix MK-677 calculator to determine accurate peptide concentration?

A mix MK-677 calculator determines final peptide concentration by dividing total peptide mass (in milligrams) by total reconstitution volume (in millilitres). For a 10mg vial reconstituted with 2mL bacteriostatic water, the calculation is 10mg ÷ 2mL = 5mg/mL. To dose 1.5mg per administration from this solution, divide target dose by concentration: 1.5mg ÷ 5mg/mL = 0.3mL per injection. This framework applies universally across all lyophilised peptides.

The mix MK-677 calculator isn't a single online tool. It's a three-step equation framework that prevents the two most common reconstitution failures: incorrect concentration assumptions and inconsistent unit conversions. Researchers who skip this calculation step are operating blind. The rest of this piece covers the exact inputs required, how to interpret vial labels that list peptide mass as 'approximately 10mg', and what preparation mistakes negate dosing accuracy entirely.

Step 1: Identify Total Peptide Mass and Confirm Vial Label Accuracy

Every lyophilised peptide vial lists total peptide mass in milligrams. Typically 5mg, 10mg, or 15mg for MK-677 ibutamoren mesylate. This number represents the active compound only, excluding excipients like mannitol or glycine that stabilise the lyophilised powder. The label '10mg' does not mean the vial contains 10mg of total powder. It means the vial contains 10mg of bioactive MK-677 within a larger powder mass that may weigh 15–20mg total.

Vial labels from 503B-registered facilities state peptide mass with +/- 10% variance due to lyophilisation loss. A vial labelled '10mg' may contain 9.0–11.0mg of active compound. This variance is pharmacologically acceptable for research applications but must be accounted for when calculating doses at the upper range of intended administration. For multi-dose protocols lasting 8–12 weeks, assume the lower bound (9mg for a 10mg vial) to avoid running short before the study period concludes.

Confirm the peptide mass before opening the vial. Once the sterile seal is broken, the lyophilised powder begins absorbing atmospheric moisture even under refrigeration, which degrades potency by 2–5% per week. Our experience working with peptide research teams shows that vials left unsealed at room temperature for 48 hours lose measurable bioactivity. The powder visibly clumps and discolours, indicating protein denaturation that no amount of reconstitution can reverse.

Laboratory preparation tool

Enter what's in the vial and how much laboratory solvent you're adding, and get the exact concentration of the resulting research solution for your lab records.

One thing to understand before you calculate: this tool — and everything we sell — is for education and laboratory research. Researchers and labs use it to prepare and document research solutions. It isn't medical advice or dosing guidance, and nothing here is for human or veterinary consumption. Full details in our Terms of Service.

Vial contentsmgLaboratory solvent addedmL

Everything this calculator returns describes a solution on a lab bench: milligrams of material, milliliters of solvent, the concentration that results. That's by design — it's an educational tool for researchers, and it offers no guidance about administering anything to anyone. What you do in your lab is governed by your institution's protocols and applicable law.

Open the Research Solution Concentration Calculator →

Step 2: Select Reconstitution Volume Based on Target Dose Precision

Reconstitution volume directly determines final peptide concentration, which in turn determines the injection volume required per dose. The mix MK-677 calculator uses this relationship: Concentration (mg/mL) = Peptide Mass (mg) ÷ Reconstitution Volume (mL). A 10mg vial reconstituted with 1mL yields 10mg/mL; the same vial reconstituted with 2mL yields 5mg/mL. Lower concentrations require larger injection volumes but allow finer dose adjustments.

For research protocols requiring doses between 1–3mg per administration, reconstitute with 2mL bacteriostatic water to achieve 5mg/mL concentration. This allows 0.2mL (1mg), 0.3mL (1.5mg), and 0.6mL (3mg) dose volumes that standard insulin syringes measure accurately. For higher doses (10–15mg), reconstitute with 1mL to achieve 10mg/mL, reducing injection volume to 1.0–1.5mL per administration. Injection volumes above 1.5mL per subcutaneous site increase tissue pressure and reduce absorption consistency.

Bacteriostatic water containing 0.9% benzyl alcohol is the only acceptable reconstitution solvent for multi-dose vials stored beyond 24 hours. Sterile water without preservative supports bacterial growth within 48 hours under refrigeration. Using it for a 30-day protocol creates contamination risk that invalidates the entire study. Real Peptides' MK-677 is supplied as lyophilised powder requiring reconstitution with bacteriostatic water before administration.

Step 3: Calculate Required Injection Volume for Target Dose

Once concentration is established, the mix MK-677 calculator determines injection volume per dose using: Injection Volume (mL) = Target Dose (mg) ÷ Concentration (mg/mL). For a 1.5mg dose from a 5mg/mL solution, the calculation is 1.5mg ÷ 5mg/mL = 0.3mL. This is the volume drawn into the syringe for each administration.

Dose consistency depends on syringe precision. Standard 1mL insulin syringes calibrated in 0.01mL increments measure volumes between 0.1–1.0mL with +/- 5% accuracy. For doses requiring volumes below 0.1mL (such as 0.05mL for a 0.25mg dose from 5mg/mL), upgrade to a 0.3mL insulin syringe calibrated in 0.005mL increments. Attempting to measure 0.05mL on a 1mL syringe introduces 15–20% dosing error due to meniscus reading variability. The difference between 0.04mL and 0.06mL at that scale.

Multi-dose protocols lasting 4–8 weeks must account for solution volume loss during repeated draws. Each syringe insertion leaves residual solution in the needle hub (approximately 0.02mL per draw), and air displacement during draws reduces vial pressure, making the final 2–3 doses harder to extract fully. For a 30-dose protocol, add 0.5mL to the initial reconstitution volume to compensate. Reconstitute a 10mg vial with 2.5mL instead of 2mL to ensure the final calculated dose remains accurate.

MK-677 Reconstitution: Volume and Concentration Comparison

Vial Size	Reconstitution Volume	Final Concentration	1mg Dose Volume	2.5mg Dose Volume	5mg Dose Volume	Professional Assessment
10mg	1mL	10mg/mL	0.1mL	0.25mL	0.5mL	Highest concentration. Best for experienced researchers requiring minimal injection volume. Requires precise syringe measurement.
10mg	2mL	5mg/mL	0.2mL	0.5mL	1.0mL	Most versatile option. Balances ease of measurement with manageable injection volume. Recommended for multi-dose protocols.
10mg	3mL	3.33mg/mL	0.3mL	0.75mL	1.5mL	Lower concentration. Allows finest dose adjustments but requires larger injection volumes that may reduce subcutaneous absorption consistency.
15mg	2mL	7.5mg/mL	0.13mL	0.33mL	0.67mL	Mid-range concentration for higher-dose protocols. Injection volumes remain under 1mL for typical research doses.
5mg	1mL	5mg/mL	0.2mL	0.5mL	1.0mL	Lower total peptide mass. Ideal for short-term studies or dose-finding experiments before committing to larger vials.

What If: MK-677 Mixing Scenarios

What If I Accidentally Add Too Much Bacteriostatic Water to the Vial?

If you've added 3mL instead of the intended 2mL to a 10mg vial, your final concentration is now 3.33mg/mL instead of 5mg/mL. Do not attempt to remove excess water with a syringe. This introduces contamination risk and disrupts sterile technique. Instead, recalculate your injection volume using the new concentration: for a 1.5mg dose, you now need 0.45mL instead of 0.3mL. The total number of available doses remains the same (the vial still contains 10mg total), but each dose requires a larger injection volume. Document the new concentration on the vial label immediately to prevent dosing errors during subsequent administrations.

What If the Lyophilised Powder Doesn't Fully Dissolve After Adding Bacteriostatic Water?

Incomplete dissolution indicates one of three problems: insufficient mixing time, incorrect solvent, or degraded peptide. After adding bacteriostatic water, gently swirl the vial in a circular motion for 60–90 seconds. Never shake vigorously, as this denatures the protein structure through mechanical stress. If powder remains visible after two minutes of gentle swirling, refrigerate the vial at 2–8°C for 10–15 minutes and swirl again. MK-677 ibutamoren mesylate dissolves readily in bacteriostatic water at physiological pH; persistent cloudiness or visible particulates suggest the peptide was exposed to temperature excursion during shipping or storage, causing irreversible aggregation. Do not administer cloudy or particulate-containing solutions. The bioactivity is compromised and injection-site reactions become likely.

What If I Need to Dose 12.5mg Per Administration But My Vial Only Contains 10mg?

For doses exceeding the total peptide mass in a single vial, you must reconstitute multiple vials and combine doses from separate syringes during the same administration. Reconstitute two 10mg vials each with 2mL bacteriostatic water (yielding 5mg/mL). Draw 1.0mL from the first vial (5mg) and 0.75mL from the second vial (3.75mg), then inject both volumes sequentially at separate subcutaneous sites spaced at least 5cm apart. Do not mix peptides from multiple vials into a single syringe before administration. This increases contamination risk and makes dose verification impossible if adverse events occur. Splitting high doses across two injection sites also reduces local tissue pressure, improving absorption consistency compared to a single 2.5mL injection.

The Unforgiving Truth About MK-677 Reconstitution

Here's the honest answer: most peptide calculation errors happen because researchers conflate peptide mass with powder mass. When the vial label says '10mg MK-677', that's 10mg of bioactive ibutamoren mesylate. Not 10mg of the white powder you see inside the vial. The total powder mass is 15–20mg because it includes mannitol, glycine, or other excipients that stabilise the lyophilised structure during storage. If you weigh the powder and try to calculate concentration based on total powder mass instead of labelled peptide mass, your concentration will be off by 30–50%, and every subsequent dose will be wrong.

The second truth: there is no 'standard' reconstitution volume. The mix MK-677 calculator doesn't prescribe 2mL as a universal rule. It matches reconstitution volume to your target dose and syringe precision. A researcher administering 0.5mg daily should reconstitute with 5mL to achieve 2mg/mL, allowing a 0.25mL injection volume that standard syringes measure accurately. A researcher administering 10mg daily should reconstitute with 1mL to achieve 10mg/mL, keeping injection volume at 1mL. The 'right' reconstitution volume is the one that makes your target dose measurable with the equipment you have.

The third truth, which suppliers rarely state plainly: peptide potency starts declining the moment you add water. Even under ideal refrigerated storage at 2–8°C, reconstituted MK-677 loses 3–5% potency per week due to hydrolytic degradation. A vial reconstituted on day one and stored for 28 days has lost 12–20% of its original bioactivity by the final dose. This isn't a storage failure. It's the thermodynamic reality of peptides in aqueous solution. For protocols requiring consistent dosing over 8+ weeks, reconstitute smaller vials more frequently rather than storing a single large-volume vial for the entire study period.

Peptide dosing accuracy isn't a convenience feature. It's the foundation of reproducible research. The difference between a valid study and invalidated data often comes down to whether the researcher calculated concentration correctly on day one. The mix MK-677 calculator is the gate between precision and guesswork. If you're not using it, you're not dosing accurately. You're approximating, and approximation compounds with every administration until the protocol is meaningless.

When reconstitution precision matters, researchers working with peptides like MK-677 from Real Peptides start with exact peptide mass, controlled reconstitution volume, and verified syringe calibration. That's not overcaution. It's the minimum standard for research-grade work. You can explore the full range of high-purity research peptides and see how precise synthesis standards extend across the complete peptide collection.

The most common mistake we see isn't miscalculation. It's researchers who assume 'close enough' dosing is acceptable because they're not working with patients. But imprecise dosing in research creates data noise that makes experimental results uninterpretable. If your concentration is off by 15% and you don't know it, every data point in your study is off by 15%, and you'll never know whether the observed effect was real or an artefact of dosing variance. The mix MK-677 calculator exists because research-grade work requires research-grade precision. Not because peptide suppliers want to complicate the process.

References

Peer-reviewed sources on MK-677 (Ibutamoren) indexed in PubMed, listed for research context. Real Peptides supplies MK-677 (Ibutamoren) for laboratory research use only.

Hepatotoxicity induced by MK-677. BMJ case reports, 2025. PMID 40675653. doi:10.1136/bcr-2025-265728
LGD-4033 and MK-677 use impacts body composition, circulating biomarkers, and skeletal muscle androgenic hormone and receptor content: A case report. Experimental physiology, 2022. PMID 36303408. doi:10.1113/EP090741
Effect of the Orally Active Growth Hormone Secretagogue MK-677 on Somatic Growth in Rats. Yonsei medical journal, 2018. PMID 30450851. doi:10.3349/ymj.2018.59.10.1174
Growth hormone secretagogue MK-677: no clinical effect on AD progression in a randomized trial. Neurology, 2008. PMID 19015485. doi:10.1212/01.wnl.0000335163.88054.e7
MK-677, an orally active growth hormone secretagogue, reverses diet-induced catabolism. The Journal of clinical endocrinology and metabolism, 1998. PMID 9467534. doi:10.1210/jcem.83.2.4551
Prolonged oral treatment with MK-677, a novel growth hormone secretagogue, improves sleep quality in man. Neuroendocrinology, 1997. PMID 9349662. doi:10.1159/000127249
Design and biological activities of L-163,191 (MK-0677): a potent, orally active growth hormone secretagogue. Proceedings of the National Academy of Sciences of the United States of America, 1995. PMID 7624358. doi:10.1073/pnas.92.15.7001

Build a pack

Researching more than one compound?

Build a multi-vial pack and the discount applies automatically as you add doses.

Start a pack

Questions

Divide your target dose in milligrams by the final concentration in mg/mL. For example, to dose 2mg from a solution with 5mg/mL concentration, calculate 2mg ÷ 5mg/mL = 0.4mL. This is the volume you draw into your syringe. The equation works universally for all peptide concentrations — always confirm your concentration before calculating injection volume.

Sterile water is acceptable only for single-use vials administered within 24 hours of reconstitution. For multi-dose vials stored beyond 24 hours, bacteriostatic water containing 0.9% benzyl alcohol is mandatory — sterile water without preservative supports bacterial growth within 48 hours under refrigeration, creating contamination risk that invalidates research protocols. Never substitute one for the other in multi-dose applications.

Target concentration depends on your intended dose per administration and syringe precision. For doses between 1–3mg, reconstitute with 2mL bacteriostatic water to achieve 5mg/mL, allowing injection volumes between 0.2–0.6mL that standard insulin syringes measure accurately. For higher doses (5–10mg), reconstitute with 1mL to achieve 10mg/mL, keeping injection volumes under 1.5mL per subcutaneous site.

Reconstituted MK-677 stored at 2–8°C in bacteriostatic water loses approximately 3–5% potency per week due to hydrolytic degradation. A vial remains usable for 28 days post-reconstitution, but researchers requiring consistent dosing over 8+ weeks should reconstitute smaller vials more frequently rather than storing a single vial for the entire protocol duration. Potency loss is cumulative and cannot be reversed.

Standard 1mL insulin syringes calibrated in 0.01mL increments measure volumes between 0.1–1.0mL with acceptable accuracy. For doses requiring volumes below 0.1mL, use a 0.3mL insulin syringe calibrated in 0.005mL increments to reduce measurement error. Attempting to measure 0.05mL on a 1mL syringe introduces 15–20% dosing variance due to meniscus reading limitations at that scale.

Vials labelled ‘approximately 10mg’ contain 9.0–11.0mg of active compound due to lyophilisation loss — a +/- 10% variance standard across 503B facilities. For multi-dose protocols lasting 8–12 weeks, calculate total available doses using the lower bound (9mg for a 10mg vial) to avoid running short before the study period concludes. This conservative approach accounts for both label variance and residual solution loss during repeated syringe draws.

Miscalculated concentration compounds with every dose administered. If you assume 10mg/mL when the actual concentration is 5mg/mL, you are administering half the intended dose at every injection — the cumulative error over 30 doses invalidates the entire research protocol. There is no post-hoc correction for concentration errors once dosing has begun. Always verify concentration immediately after reconstitution and document it on the vial label.

Combining reconstituted peptides from multiple vials into a single container is not recommended. Each transfer introduces contamination risk, increases air exposure that accelerates degradation, and makes dose verification impossible if adverse events occur. For protocols requiring high total peptide mass, reconstitute vials individually and administer doses from separate syringes at the same time rather than pooling solutions.

MK-677 research protocols typically involve milligram-scale doses (1–25mg per administration), making milligrams the practical unit for calculation. Using micrograms (1mg = 1000mcg) introduces unnecessary decimal-point errors during manual calculation. The mix MK-677 calculator maintains unit consistency — peptide mass in mg, volume in mL, concentration in mg/mL — to reduce conversion mistakes that compound across multi-dose protocols.

Do not administer cloudy or particulate-containing solutions. Cloudiness indicates protein aggregation caused by temperature excursion, mechanical stress during shipping, or degraded peptide. MK-677 dissolved in bacteriostatic water should be completely clear and colourless. Persistent cloudiness after refrigeration and gentle swirling means the peptide structure is irreversibly compromised — discard the vial and obtain a replacement from the supplier.

RESEARCH USE ONLY · NOT EVALUATED BY THE FDA